Market Overview

UPDATE: Sterne Agee Upgrades DST Systems to Buy on Asset Monetization

Related DST
Cigna Renews Relationship With Argus Health For Pharmacy Solutions
DST System 8-K Filing: Completes Sale And Leaseback Transaction, Proceeds Were $107.3M; Enters Similar Agreement & May Generate Proceeds Of $21.7M

Sterne Agee raised its rating on DST Systems (NYSE: DST) from Neutral to Buy with a $71 price target.

Sterne Agee commented, "We believe DST is on a clear path to monetize a significant amount of its non-core assets, something investors have waited years to see. As monetization events occur, we expect the stock to continue to respond positively. Our sum-of-the-parts analysis yields a fair value of $71, but we note that there are multiple points of conservatism in our analysis. On a fundamental basis, we expect to see improving trends in 2013."

DST Systems closed at $61.85 on Thursday.

Latest Ratings for DST

Jul 2015BairdDowngradesOutperformNeutral
Apr 2015Credit SuisseDowngradesOutperformNeutral
Jul 2014Credit SuisseMaintainsOutperform

View More Analyst Ratings for DST
View the Latest Analyst Ratings

Posted-In: Sterne AgeeAnalyst Color Upgrades Pre-Market Outlook Analyst Ratings


Related Articles (DST)

View Comments and Join the Discussion!

Get Benzinga's Newsletters